National Cancer Institute

People with a high polygenic risk score for colorectal cancer could benefit more at preventing the disease by leading healthy lifestyles than those at lower genetic risk, according to a study by Vanderbilt researchers published in the April issue of The American Journal of Clinical Nutrition. Read More

A new genome-wide CRISPR screening technique conducted by researchers at Vanderbilt University is offering new insights about how tumors in 80 to 90 percent of all cancers grow. Read More

Vanderbilt researchers have received a National Cancer Institute grant to develop a novel, integrative approach to detect early signs of lung cancer. The four-year project builds on a related, recent study that established the value of using three separate measures—structural imaging, a protein marker and information available from electronic health records—to predict lung cancer in... Read More

While 60 percent of people with metastatic melanoma, an aggressive type of skin cancer, have multiple treatment options available to them, roughly 40 percent either do not respond to treatment, or relapse. Read More

Rebecca Ihrie and Jonathan Irish are leading the development of machine learning applications for brain cancer research. Read More

Zhijun Yin, PhD, assistant professor of Biomedical Informatics at Vanderbilt University Medical Center, has received the National Cancer Institute’s Method to Extend Research in Time Award (or MERIT Award) for Early Stage Investigators. Read More

A multidisciplinary team of investigators at Vanderbilt University and Vanderbilt University Medical Center has received a program project grant from the National Cancer Institute to explore extracellular RNA in colorectal cancer. Read More

Researchers from Vanderbilt-Ingram Cancer Center (VICC) discovered a role for MYCN in triple-negative breast cancer (TNBC), a particularly aggressive form of the disease, and identified a potential intervention for further clinical investigation. Read More

Colorectal cancer researchers from Vanderbilt-Ingram Cancer Center (VICC) have been awarded a Specialized Program of Research Excellence grant from the National Cancer Institute (NCI). Read More

Breast cancer researchers at Vanderbilt-Ingram Cancer Center have secured a fourth round of continuous Specialized Program of Research Excellence funding. Read More

A five-year National Cancer Institute grant will fund an interdisciplinary research center for the study of small cell lung cancer, a highly aggressive, incurable form of the disease. Read More

Living in an economically disadvantaged neighborhood is likely to lead to death at an earlier age, especially among African-Americans, new research shows. The death rate is even more pronounced among disadvantaged individuals with unhealthy lifestyle habits. Read More

Vanderbilt’s Robert Coffey Jr., M.D., has received an Outstanding Investigator Award from the National Cancer Institute (NCI) — more than $6.6 million over seven years — to support studies aimed at advancing the diagnosis and treatment of colorectal cancer (CRC), a leading cancer killer. Read More

Douglas Lowy, M.D., acting director of the National Cancer Institute (NCI), warned that worldwide death rates from cervical cancer are expected to increase in low- and middle-income countries during the next 15 years unless steps are taken to prevent the cancer from occurring. Almost all cases of cervical cancer are linked to a viral infection. Read More

Kamakoti “Kami” Bhat, a fifth-year graduate student in the lab of David Cortez, Ph.D., professor of Biochemistry in the School of Medicine, has achieved a “first” for Vanderbilt University. Read More

Scientists in the Vanderbilt Epidemiology Center (VEC) and Vanderbilt-Ingram Cancer Center (VICC) have been awarded a grant to plan and develop a Regional Center of Research Excellence in non-communicable diseases in Vietnam. Read More

The National Cancer Institute has announced the Outstanding Investigator Award funding opportunity. The OIA will support investigators with outstanding records of productivity in cancer research with up to $600,000 in direct costs per year for seven years to provide funding stability. Read More

A cancer research consortium headed by investigators at Vanderbilt-Ingram Cancer Center and two other institutions have received $12 million in federal funding to help determine why African-American women die at a higher rate and have more aggressive breast cancer than white women. Read More

Nearly half of all patients with malignant melanoma, the most deadly form of skin cancer, have a mutation in the BRAF gene found in their tumors. Mutations in the BRAF gene turn on a cancer growth switch known as the MAP kinase pathway. Read More

Vanderbilt-Ingram Cancer Center (VICC) has been recognized for the impact of its research programs and excellence in patient care by a panel of National Cancer Institute (NCI) reviewers, receiving an overall “exceptional” score as part of the renewal of the Cancer Center Support Grant (CCSG). Read More